Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung Cancer-Reference-Cited by-同舟云学术

Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung Cancer

Published:2018-11 Issue:6 Volume:19 Page:e913-e918
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Wu Fang,Lin Xiaoping,Yang Zhanghuan,Sun Ziyi,Zeng Fanxu,Heng Jianfu,Qu Jingjing,Zeng Liang,Yang Nong,Zhang Yongchang

Funder

National Natural Science Foundation

Hunan Natural Science Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference24 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Cisplatin in cancer therapy: molecular mechanisms of action;Dasari;Eur J Pharmacol,2014

3. Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: a systematic review;Sommariva;Crit Rev Oncol Hematol,2016

4. Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2388 health care providers;Van Laar;Support Care Cancer,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two doses of fosaprepitant included prophylactic treatment for the three-day cisplatin-based chemotherapy induced nausea and vomiting;Journal of Cancer Research and Clinical Oncology;2024-06-05

2. A Systematic Review of Literatures: To Identify Non-Cancer Drugs Repurposed for Lung Cancer;2023-12-04

3. Efficacy and safety of Aprepitant-containing triple therapy for the prevention and treatment of chemotherapy-induced nausea and vomiting: A meta-analysis;Medicine;2023-11-24

4. Prolonged administration of aprepitant improves cisplatin-based chemotherapy-induced nausea and vomiting;Future Oncology;2022-06

5. Use of dexamethasone and a 5-HT3 receptor antagonist with or without aprepitant to prevent chemotherapy-induced nausea and vomiting among patients with lung cancer who are treated with platinum-based chemotherapy: a systematic review and meta-analysis of randomized controlled trials;Annals of Palliative Medicine;2021-04